IMMUNIC, INC. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Immunic, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Immunic, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$22.8M, a 8.82% increase year-over-year.
  • Immunic, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$93.6M, a 27.8% increase year-over-year.
  • Immunic, Inc. annual Operating Income (Loss) for 2023 was -$99.2M, a 17% increase from 2022.
  • Immunic, Inc. annual Operating Income (Loss) for 2022 was -$119M, a 30.4% decline from 2021.
  • Immunic, Inc. annual Operating Income (Loss) for 2021 was -$91.7M, a 87.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$99.2M +$20.3M +17% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$119M -$27.8M -30.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$91.7M -$42.7M -87.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 -$49M -$11.9M -32.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$37M -$25M -209% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-26
2018 -$12M +$40.7M +77.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$52.7M -$11.4M -27.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-04
2016 -$41.3M +$10.9M +20.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-04
2015 -$52.1M -$1.78M -3.53% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$50.3M -$18.9M -60.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
2013 -$31.4M -$21.8M -228% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 -$9.58M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.